Regulator asks Australian Clinical Labs to divest collection centres
Oct 3 (Reuters) - Australia's competition watchdog on Tuesday said Australian Clinical Labs' ACL.AX proposed acquisition of medical centre operator Healius HLS.AX would require it to divest its approved collection centres (ACCs) in Australia's Northern Territory. (Reporting by Ayushman Ojha; Editing by Maju Samuel) ((Ayushman.Ojha@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million